Jiaxin Li
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 7
- Phytochemistry and Bioactivity Studies 4
-
- Cancer Immunotherapy and Biomarkers 6
-
- Traditional Chinese Medicine Analysis 4
-
- Gastric Cancer Management and Outcomes 6
- Lung Cancer Treatments and Mutations 5
-
- Liver Disease Diagnosis and Treatment 5
-
- Natural product bioactivities and synthesis 4
- Co-authors
- Peiyu YanElaine Lai‐Han LeungAo SunJumin HuangZebo JiangTu-Liang LiangXuan‐Run WangRunze Li
- Cited by
- PharmacologyCancer ResearchOncology
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Jiaxin Li
71 papers receiving 793 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 97
- Cancer Research 113
- Oncology 189
- Complementary and alternative medicine 48
- Immunology 96
Countries citing papers authored by Jiaxin Li
This map shows the geographic impact of Jiaxin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxin Li more than expected).
Fields of papers citing papers by Jiaxin Li
This network shows the impact of papers produced by Jiaxin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxin Li. The network helps show where Jiaxin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiaxin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 15 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 13 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 0 | |
| 12 | 2024 | 1 | |
| 13 | 2024 | 0 | |
| 14 | 2023 | 0 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2023 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2021 | 4 | |
| 20 | 2012 | 19 |
About Jiaxin Li
Jiaxin Li is a scholar working on Pharmacology, Oncology and Gastroenterology, having authored 81 papers that have together received 806 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (7 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Phytochemistry and Bioactivity Studies (4 papers), Traditional Chinese Medicine Analysis (4 papers) and Natural product bioactivities and synthesis (4 papers). The work is most often cited by research in Pharmacology (97 citations), Cancer Research (113 citations) and Oncology (189 citations). Jiaxin Li has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Peiyu Yan, Elaine Lai‐Han Leung, Ao Sun, Jumin Huang, Zebo Jiang, Tu-Liang Liang, Xuan‐Run Wang, Runze Li, Qibiao Wu and Xiaojun Yao. Their work appears in journals such as PLoS ONE, Journal of Hazardous Materials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.